pCDCAR1 CD19 h(ζ)(CAR-MZ125)

The vector of anti-CD19 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human CD19. The T cells are genetically modified through transduction with a retroviral vector expressing scFv of anti-CD19 antibody linked to CD3ζ signaling domains. And the vector product was designed for the treatment of Acute lymphoblastic leukemia .

Details

Target

CD19

Target Species

Human

Targeting Cell Type

T cell

Targeting Diseases

Acute lymphoblastic leukemia

Generation

First

Vector Name

pCDCAR1

Vector Length

~8kb

Vector Type

Retroviral

Receptor Construction

scFv-CD3ζ

Discription of Signaling Cassetes

CD3ζCD3ζ, also known as T-cell receptor zeta, which together with T-cell receptor and CD3γ, δ , ε chain, forms the TCR-CD3 complex. ζ was expressed independently from the complex. The zeta chain plays an important role in coupling antigen recognition to several intracellular signal-transduction pathways. CD3-zeta, which contains 3 ITAMs, is the most commonly used endodomain component of CARs. It transmits an activation signal to the T cell after antigen is bound. CD3-zeta may not provide a fully competent activation signal and additional co-stimulatory signaling is needed. For example, chimeric CD28 and OX40 can be used with CD3-zeta to transmit a proliferative/survival signal, or all three can be used together.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.